OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases.

Through an extensive portfolio of high-performance stents and balloons, OrbusNeich provides proven solutions to interventional cardiologists worldwide.




OrbusNeich leads the way in pro-healing stent technology. COMBO™, the world’s first dual therapy stent accelerates endothelial coverage and controls neo-intimal proliferation through the combination of the Genous EPC capture technology with an abluminal sirolimus drug elution.
B. Wayne Johnson Named OrbusNeich President and Chief Executive Officer... READ MORE...

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and Orb... READ MORE...
Visit us at European Society of Cardiology 2014 (ESC), Barcelona, Spain, August 30 - September 3 READ MORE...

Visit us at Transcatheter Cardiovascular Therapeutics 2014, Washington DC, USA, September 13-17 READ MORE...